1 Comment
User's avatar
⭠ Return to thread
Stephen Strum, MD, FACP's avatar

Edward, please don't confuse the message with the messenger. Finding prostate cancer vis-à-vis the PSA and its derivatives did not and does not have to equate with over-treatment by an uninformed and often greedy medical doctor or medical center. Often such patients can be "treated" with diet and lifestyle changes that alter the individual's biological milieu. We are just recently also learning the importance of the gut and bladder microbiome on the "establishment" of cancers of the prostate and bladder.

After the decision to stop PSA screening, there has been a surge in advanced prostate cancer and death due to PC. In medicine, we have to follow what we are taught (or tried to be taught) in med school: Primum Non Nocere or First (above all) Do No Harm.

Good medicine is like the popular CSI series on TV. We in the medical field must learn to profile individual patients using the available tools-- from family history, to genetic assessments, to patient input, physical exam, baseline and follow-up labs looking for trends, and also the benefits of artificial intelligence (AI) and machine learning (ML). I was diagnosed very late with.a rare and horrendous B-cell malignancy called light chain amyloidosis (AL). Using my history, and an AI program on the Internet (Symptoma), the diagnosis of AL was the top choice of what I had. An earlier diagnosis would have changed my life immensely.

Expand full comment